Micron Biomedical, a clinical stage company developing dissolvable, needle-free products that could replace injectable pharmaceuticals and vaccines, today announced it was named to the number two spot ...

Botstein, Princeton’s Anthony B. Evnin ‘62 Professor of Genomics, Emeritus, and an emeritus professor of molecular biology ...

Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries ...

Alongside the rebrand, Terrestrial is planning to establish a new headquarters and manufacturing facility in Boston.

Genomics improves healthcare and prevention of all major diseases by early personalized insight into health, and Europe needs ...

Vaxess Technologies today announced a rebranding to Terrestrial Bio, Inc., along with $50 million in Series C financing.

The global digital dentistry market is growing steadily, expected to be valued at around US$ 7.2 billion in 2026 and ...

Get our Editor-in-Chief Michelle Itano's BioTechniques Q1 2026 highlights, featuring an optimized Southern blot protocol and ...

This year’s most innovative smaller companies prove that head count doesn’t cap ambition. These Small and Mighty standouts (51 to 200 employees) are thinking well beyond their ...

A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in advanced automation for ...